US Stock MarketDetailed Quotes
EVAX Evaxion Biotech
- 1.500
- +0.010+0.67%
Trading Nov 25 14:43 ET
8.80MMarket Cap-535P/E (TTM)
1.760High1.412Low52.20KVolume1.500Open1.490Pre Close82.63KTurnover1.39%Turnover RatioLossP/E (Static)5.87MShares13.61052wk High115.38P/B5.62MFloat Cap1.28052wk Low--Dividend TTM3.74MShs Float250.400Historical High--Div YieldTTM23.34%Amplitude1.280Historical Low1.582Avg Price1Lot Size
About Evaxion Biotech Company
Evaxion Biotech A/S engages in the discovery and development of immunotherapies for cancer and infectious diseases. Its technologies include the immuno-oncology platform PIONEER, the bacterial disease platform EDEN, the viral disease platform RAVEN, and the proprietary AI platform technology ObsERV. The company was founded by Niels Iversen M?ller and Andreas Holm Mattsson on August 11, 2008 and is headquartered in Hoersholm, Denmark.
Company Profile
SymbolEVAX
Company NameEvaxion Biotech
Listing DateFeb 5, 2021
Issue Price10.00
Founded2008
CEOMr. Christian Kanstrup
MarketNASDAQ
Employees49
Securities TypeDR
ADS Ratio1.0 : 10.0
Fiscal Year Ends12-31
AddressDr. Neergaards Vej 5F
CityHoersholm
ProvinceNorth Denmark
CountryDenmark
Zip Code2970
Phone45-53-53-18-50
Company Executives
- Name
- Position
- Salary
- Christian Kanstrup
- Chief Executive Officer
- --
- Jesper Nyegaard Nissen
- Chief Operating Officer and Chief Financial Officer
- --
- Andreas Holm Mattsson
- Chief AI and Culture Officer
- --
- Birgitte Rono
- Chief Scientific Officer
- --
- Marianne Sogaard
- Chairman of Board
- 163.00K
- Dr. Niels Iversen Moller
- Director
- 74.00K
- Roberto Prego
- Independent Director
- 63.00K
- Lars Holtug
- Independent Director
- 59.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data